Fund Holdings — MPM ASSET MANAGEMENT LLC

Total Portfolio Value:
$69.44M
Total Bought:
$2.15M
Total Sold:
$3.04M
Net Transaction:
-$891.9K
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Entrada Therapeutics, Inc.(TRDA)4,381,0624,381,0620$75.75M$39.60M57.04%-$36.14M
iTeos Therapeutics, Inc.2,738,7852,738,7850$21.03M$16.35M23.55%-$4.68M
Dyne Therapeutics, Inc.(DYN)682,376682,3760$16.08M$7.14M10.28%-$8.94M
Werewolf Therapeutics, Inc.(HOWL)4,284,1724,309,860+25,688$6.34M$4.19M6.03%-$2.15M
Repare Therapeutics, Inc.1,683,7071,121,318-562,389$2.21M$1.11M1.59%-$1.10M
Adaptimmune Therapeutics plcADR(ADAPY)5,555,4615,335,715-219,746$2.99M$1.05M1.51%-$1.94M
Page 1 of 1
MPM ASSET MANAGEMENT LLC — 13F Holdings — Q1 2025 | TickerTrail